{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T06:38:12Z","timestamp":1774334292507,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2016A020216021"],"award-info":[{"award-number":["2016A020216021"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Planning Project of Guangzhou","award":["201604020006"],"award-info":[{"award-number":["201604020006"]}]},{"name":"National Science and Technology Key Projects on \u201cMajor Infectious Diseases such as HIV\/AIDS, Viral Hepatitis Prevention and Treatment\u201d","award":["2018ZX10715004-002, 2017ZX10201302-005, 2018ZX10103001-001-004"],"award-info":[{"award-number":["2018ZX10715004-002, 2017ZX10201302-005, 2018ZX10103001-001-004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Evol"],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Drug-resistant <jats:italic>Mycobacterium tuberculosis<\/jats:italic> (<jats:italic>M. tuberculosis<\/jats:italic>) has become an increasingly serious public health problem and has complicated tuberculosis (TB) treatment. Levofloxacin (LOF) is an ideal anti-tuberculosis drug in clinical applications. However, the detailed molecular mechanisms of LOF-resistant <jats:italic>M. tuberculosis<\/jats:italic> in TB treatment have not been revealed. Our study performed transcriptome and methylome sequencing to investigate the potential biological characteristics of LOF resistance in <jats:italic>M. tuberculosis<\/jats:italic> H37Rv. In the transcriptome analysis, 953 differentially expressed genes (DEGs) were identified; 514 and 439 DEGs were significantly downregulated and upregulated in the LOF-resistant group and control group, respectively. The KEGG pathway analysis revealed that 97 pathways were enriched in this study. In the methylome analysis, 239 differentially methylated genes (DMGs) were identified; 150 and 89 DMGs were hypomethylated and hypermethylated in the LOF-resistant group and control group, respectively. The KEGG pathway analysis revealed that 74 pathways were enriched in this study. The overlap study suggested that 25 genes were obtained. It was notable that nine genes expressed downregulated mRNA and upregulated methylated levels, including <jats:italic>pgi<\/jats:italic>, <jats:italic>fadE4<\/jats:italic>, <jats:italic>php<\/jats:italic>, <jats:italic>cyp132<\/jats:italic>, <jats:italic>pckA<\/jats:italic>, <jats:italic>rpmB1<\/jats:italic>, <jats:italic>pfkB<\/jats:italic>, <jats:italic>acg<\/jats:italic>, and <jats:italic>ctpF<\/jats:italic>, especially <jats:italic>cyp132<\/jats:italic>, <jats:italic>pckA<\/jats:italic>, and <jats:italic>pfkB<\/jats:italic>, which were vital in LOF-resistant <jats:italic>M. tuberculosis<\/jats:italic> H37Rv. The overlapping genes between transcriptome and methylome could be essential for studying the molecular mechanisms of LOF-resistant <jats:italic>M. tuberculosis<\/jats:italic> H37Rv. These results may provide informative evidence for TB treatment with LOF.<\/jats:p>","DOI":"10.1007\/s00239-019-09926-z","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T07:11:56Z","timestamp":1578553916000},"page":"202-209","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Potential Genes Related to Levofloxacin Resistance in Mycobacterium tuberculosis Based on Transcriptome and Methylome Overlap Analysis"],"prefix":"10.1007","volume":"88","author":[{"given":"Hai-cheng","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-xin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu-hua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-zhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gao-po","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun-xun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,9]]},"reference":[{"key":"9926_CR1","doi-asserted-by":"publisher","first-page":"e1002091","DOI":"10.1371\/journal.ppat.1002091","volume":"7","author":"DJV Beste","year":"2011","unstructured":"Beste DJV et al (2011) 13C metabolic flux analysis identifies an unusual route for pyruvate dissimilation in mycobacteria which requires isocitrate lyase and carbon dioxide fixation. PLoS Pathog 7:e1002091","journal-title":"PLoS Pathog"},{"key":"9926_CR2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00253-011-3557-z","volume":"92","author":"F Collin","year":"2011","unstructured":"Collin F, Karkare S, Maxwell A (2011) Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. Appl Microbiol Biotechnol 92:479\u2013497. https:\/\/doi.org\/10.1007\/s00253-011-3557-z","journal-title":"Appl Microbiol Biotechnol"},{"key":"9926_CR3","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1093\/jac\/dkw164","volume":"71","author":"S Ghimire","year":"2016","unstructured":"Ghimire S et al (2016) Pharmacokinetic\/pharmacodynamic-based optimization of levofloxacin administration in the treatment of MDR-TB. J Antimicrob Chemother 71:2691\u20132703. https:\/\/doi.org\/10.1093\/jac\/dkw164","journal-title":"J Antimicrob Chemother"},{"key":"9926_CR5","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1371\/journal.pgen.0030161","volume":"3","author":"JT Leek","year":"2007","unstructured":"Leek JT, Storey JD (2007) Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet 3:1724\u20131735. https:\/\/doi.org\/10.1371\/journal.pgen.0030161","journal-title":"PLoS Genet"},{"key":"9926_CR6","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1093\/bioinformatics\/btp336","volume":"25","author":"R Li","year":"2009","unstructured":"Li R, Yu C, Li Y, Lam TW, Yiu SM, Kristiansen K, Wang J (2009) SOAP2: an improved ultrafast tool for short read alignment. Bioinformatics (Oxford, England) 25:1966\u20131967. https:\/\/doi.org\/10.1093\/bioinformatics\/btp336","journal-title":"Bioinformatics (Oxford, England)"},{"key":"9926_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature08514","volume":"462","author":"R Lister","year":"2009","unstructured":"Lister R et al (2009) Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462:315\u2013322. https:\/\/doi.org\/10.1038\/nature08514","journal-title":"Nature"},{"key":"9926_CR8","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8","journal-title":"Genome Biol"},{"key":"9926_CR9","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1128\/aac.49.9.3803-3809.2005","volume":"49","author":"CT Madsen","year":"2005","unstructured":"Madsen CT, Jakobsen L, Douthwaite S (2005) Mycobacterium smegmatis Erm(38) is a reluctant dimethyltransferase. Antimicrob Agents Chemother 49:3803\u20133809. https:\/\/doi.org\/10.1128\/aac.49.9.3803-3809.2005","journal-title":"Antimicrob Agents Chemother"},{"key":"9926_CR10","doi-asserted-by":"publisher","first-page":"843","DOI":"10.2147\/tcrm.s3426","volume":"4","author":"JC McGregor","year":"2008","unstructured":"McGregor JC, Allen GP, Bearden DT (2008) Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis. Therap Clin Risk Manag 4:843\u2013853. https:\/\/doi.org\/10.2147\/tcrm.s3426","journal-title":"Therap Clin Risk Manag"},{"key":"9926_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/MCP.0b013e328337573e","volume":"16","author":"GB Migliori","year":"2010","unstructured":"Migliori GB, Centis R, Lange C, Richardson MD, Sotgiu G (2010) Emerging epidemic of drug-resistant tuberculosis in Europe, Russia, China, South America and Asia: current status and global perspectives. Curr Opin Pulmonary Med 16:171\u2013179. https:\/\/doi.org\/10.1097\/MCP.0b013e328337573e","journal-title":"Curr Opin Pulmonary Med"},{"key":"9926_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/npp.2012.112","volume":"38","author":"LD Moore","year":"2013","unstructured":"Moore LD, Le T, Fan G (2013) DNA methylation and its basic function. Neuropsychopharmacology 38:23\u201338. https:\/\/doi.org\/10.1038\/npp.2012.112","journal-title":"Neuropsychopharmacology"},{"key":"9926_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4103\/0019-5545.39762","volume":"50","author":"N Moorthy","year":"2008","unstructured":"Moorthy N, Raghavendra N, Venkatarathnamma PN (2008) Levofloxacin-induced acute psychosis. Indian J Psychiatry 50:57\u201358. https:\/\/doi.org\/10.4103\/0019-5545.39762","journal-title":"Indian J Psychiatry"},{"key":"9926_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/bmb\/ldh047","volume":"73\u201374","author":"LP Ormerod","year":"2005","unstructured":"Ormerod LP (2005) Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment. Br Med Bull 73\u201374:17\u201324. https:\/\/doi.org\/10.1093\/bmb\/ldh047","journal-title":"Br Med Bull"},{"key":"9926_CR15","doi-asserted-by":"publisher","first-page":"6938","DOI":"10.1073\/pnas.1814700116","volume":"116","author":"A Pacis","year":"2019","unstructured":"Pacis A et al (2019) Gene activation precedes DNA demethylation in response to infection in human dendritic cells. Proc Natl Acad Sci 116:6938. https:\/\/doi.org\/10.1073\/pnas.1814700116","journal-title":"Proc Natl Acad Sci"},{"key":"9926_CR16","doi-asserted-by":"publisher","DOI":"10.1101\/gr.192005.115","author":"A Pacis","year":"2015","unstructured":"Pacis A et al (2015) Bacterial infection remodels the DNA methylation landscape of human dendritic cells. Genome Res. https:\/\/doi.org\/10.1101\/gr.192005.115","journal-title":"Genome Res"},{"key":"9926_CR17","doi-asserted-by":"publisher","first-page":"e56037","DOI":"10.1371\/journal.pone.0056037","volume":"8","author":"WY Phong","year":"2013","unstructured":"Phong WY, Lin W, Rao SP, Dick T, Alonso S, Pethe K (2013) Characterization of phosphofructokinase activity in Mycobacterium tuberculosis reveals that a functional glycolytic carbon flow is necessary to limit the accumulation of toxic metabolic intermediates under hypoxia. PLoS ONE 8:e56037. https:\/\/doi.org\/10.1371\/journal.pone.0056037","journal-title":"PLoS ONE"},{"key":"9926_CR18","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ijantimicag.2013.02.011","volume":"41","author":"S Phunpruch","year":"2013","unstructured":"Phunpruch S, Warit S, Suksamran R, Billamas P, Jaitrong S, Palittapongarnpim P, Prammananan T (2013) A role for 16S rRNA dimethyltransferase (ksgA) in intrinsic clarithromycin resistance in Mycobacterium tuberculosis. Int J Antimicrob Agents 41:548\u2013551. https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.02.011","journal-title":"Int J Antimicrob Agents"},{"key":"9926_CR19","doi-asserted-by":"publisher","first-page":"e29461","DOI":"10.1371\/journal.pone.0029461","volume":"6","author":"EA Ramos","year":"2011","unstructured":"Ramos EA et al (2011) Epigenetic changes of CXCR4 and its ligand CXCL12 as prognostic factors for sporadic breast cancer. PLoS ONE 6:e29461. https:\/\/doi.org\/10.1371\/journal.pone.0029461","journal-title":"PLoS ONE"},{"key":"9926_CR20","doi-asserted-by":"publisher","first-page":"33763","DOI":"10.1074\/jbc.M305963200","volume":"278","author":"C Recchi","year":"2003","unstructured":"Recchi C, Sclavi B, Rauzier J, Gicquel B, Reyrat JM (2003) Mycobacterium tuberculosis Rv1395 is a class III transcriptional regulator of the AraC family involved in cytochrome P450 regulation. J Biol Chem 278:33763\u201333773. https:\/\/doi.org\/10.1074\/jbc.M305963200","journal-title":"J Biol Chem"},{"key":"9926_CR21","first-page":"39","volume":"57","author":"L Richeldi","year":"2002","unstructured":"Richeldi L et al (2002) Clinical use of Levofloxacin in the long-term treatment of drug resistant tuberculosis. Monaldi Arch Chest Dis 57:39\u201343","journal-title":"Monaldi Arch Chest Dis"},{"key":"9926_CR22","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrg1655","volume":"6","author":"KD Robertson","year":"2005","unstructured":"Robertson KD (2005) DNA methylation and human disease. Nat Rev Genetics 6:597\u2013610. https:\/\/doi.org\/10.1038\/nrg1655","journal-title":"Nat Rev Genetics"},{"key":"9926_CR23","first-page":"1023","volume":"28","author":"M Saleem","year":"2015","unstructured":"Saleem M et al (2015) Review-epigenetic therapy for cancer. Pak J Pharm Sci 28:1023\u20131032","journal-title":"Pak J Pharm Sci"},{"key":"9926_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1046\/j.1365-2958.2003.03425.x","volume":"48","author":"CM Sassetti","year":"2003","unstructured":"Sassetti CM, Boyd DH, Rubin EJ (2003) Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 48:77\u201384","journal-title":"Mol Microbiol"},{"key":"9926_CR25","doi-asserted-by":"publisher","first-page":"12989","DOI":"10.1073\/pnas.2134250100","volume":"100","author":"CM Sassetti","year":"2003","unstructured":"Sassetti CM, Rubin EJ (2003) Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci USA 100:12989\u201312994. https:\/\/doi.org\/10.1073\/pnas.2134250100","journal-title":"Proc Natl Acad Sci USA"},{"key":"9926_CR26","doi-asserted-by":"publisher","first-page":"a017863","DOI":"10.1101\/cshperspect.a017863","volume":"5","author":"KJ Seung","year":"2015","unstructured":"Seung KJ, Keshavjee S, Rich ML (2015) Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. Cold Spring Harb Perspect Med 5:a017863. https:\/\/doi.org\/10.1101\/cshperspect.a017863","journal-title":"Cold Spring Harb Perspect Med"},{"key":"9926_CR27","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/mmi.13350","volume":"99","author":"L Shi","year":"2016","unstructured":"Shi L et al (2016) Carbon flux rerouting during Mycobacterium tuberculosis growth arrest. Mol Microbiol 99:1179. https:\/\/doi.org\/10.1111\/mmi.13350","journal-title":"Mol Microbiol"},{"key":"9926_CR28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.rppnen.2017.10.009","volume":"24","author":"S Tiberi","year":"2018","unstructured":"Tiberi S, Munoz-Torrico M, Duarte R, Dalcolmo M, D'Ambrosio L, Migliori GB (2018) New drugs and perspectives for new anti-tuberculosis regimens. Pulmonology 24:86\u201398. https:\/\/doi.org\/10.1016\/j.rppnen.2017.10.009","journal-title":"Pulmonology"},{"key":"9926_CR29","doi-asserted-by":"publisher","first-page":"e1002287","DOI":"10.1371\/journal.ppat.1002287","volume":"7","author":"S Watanabe","year":"2011","unstructured":"Watanabe S, Zimmermann M, Goodwin MB, Sauer U, Barry CE 3rd, Boshoff HI (2011) Fumarate reductase activity maintains an energized membrane in anaerobic Mycobacterium tuberculosis. PLoS Pathog 7:e1002287. https:\/\/doi.org\/10.1371\/journal.ppat.1002287","journal-title":"PLoS Pathog"},{"key":"9926_CR30","volume-title":"Global tuberculosis report 2018","author":"WHO","year":"2018","unstructured":"WHO (2018) Global tuberculosis report 2018. WHO, Geneva"},{"key":"9926_CR4","first-page":"72","volume":"2","author":"WHO Geneva\/IUATLD Paris, International Union Against Tuberculosis and Lung Disease","year":"1998","unstructured":"WHO Geneva\/IUATLD Paris, International Union Against Tuberculosis and Lung Disease (1998) Guidelines for surveillance of drug resistance in tuberculosis. Int J Tuberc Lung Dis 2:72\u201389","journal-title":"Int J Tuberc Lung Dis"},{"key":"9926_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3329\/jhpn.v28i2.4879","volume":"28","author":"K Zaman","year":"2010","unstructured":"Zaman K (2010) Tuberculosis: a global health problem. J Health Popul Nutr 28:111\u2013113","journal-title":"J Health Popul Nutr"},{"key":"9926_CR32","doi-asserted-by":"publisher","first-page":"e1002517","DOI":"10.1371\/journal.pgen.1002517","volume":"8","author":"J Zhuang","year":"2012","unstructured":"Zhuang J et al (2012) The dynamics and prognostic potential of DNA methylation changes at stem cell gene loci in women's cancer. PLoS Genet 8:e1002517. https:\/\/doi.org\/10.1371\/journal.pgen.1002517","journal-title":"PLoS Genet"},{"key":"9926_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1755-8794-1-18","volume":"1","author":"A Zvi","year":"2008","unstructured":"Zvi A, Ariel N, Fulkerson J, Sadoff JC, Shafferman A (2008) Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses. BMC Med Genom 1:18. https:\/\/doi.org\/10.1186\/1755-8794-1-18","journal-title":"BMC Med Genom"}],"container-title":["Journal of Molecular Evolution"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00239-019-09926-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00239-019-09926-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00239-019-09926-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T01:01:11Z","timestamp":1610067671000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00239-019-09926-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,9]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["9926"],"URL":"https:\/\/doi.org\/10.1007\/s00239-019-09926-z","relation":{},"ISSN":["0022-2844","1432-1432"],"issn-type":[{"value":"0022-2844","type":"print"},{"value":"1432-1432","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,9]]},"assertion":[{"value":"24 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}